BioCentury | Nov 1, 2010
Company News

Therasis, Takeda deal

...Therasis will use its Therasis Filter technology to investigate and identify properties of a portfolio of...
...development. Therasis will receive an undisclosed upfront as well as research-related and clinical milestone payments. Therasis Inc....
BioCentury | Dec 14, 2009
Financial News

Therasis completes venture financing

Therasis Inc. , New York, N.Y. Business: Cancer Date completed: 12/8/09 Type: Venture financing Raised: $12 million Investor: Tilocor Life Sciences Note: The company said it secured $12 million in its series A. WIR Staff...
BioCentury | Dec 9, 2009
Financial News

Therasis secures $12 million

...Cancer company Therasis Inc. (New York, N.Y.) secured $12 million in a series A round from Tilocor...
...A round from Tilocor Life Science. Therasis plans to develop a cancer pipeline using its Therasis...
Items per page:
1 - 3 of 3
BioCentury | Nov 1, 2010
Company News

Therasis, Takeda deal

...Therasis will use its Therasis Filter technology to investigate and identify properties of a portfolio of...
...development. Therasis will receive an undisclosed upfront as well as research-related and clinical milestone payments. Therasis Inc....
BioCentury | Dec 14, 2009
Financial News

Therasis completes venture financing

Therasis Inc. , New York, N.Y. Business: Cancer Date completed: 12/8/09 Type: Venture financing Raised: $12 million Investor: Tilocor Life Sciences Note: The company said it secured $12 million in its series A. WIR Staff...
BioCentury | Dec 9, 2009
Financial News

Therasis secures $12 million

...Cancer company Therasis Inc. (New York, N.Y.) secured $12 million in a series A round from Tilocor...
...A round from Tilocor Life Science. Therasis plans to develop a cancer pipeline using its Therasis...
Items per page:
1 - 3 of 3